PERMANENT DISABILITIES IN CHILDHOOD SURVIVORS OF LANGERHANS CELL HISTIOCYTOSIS

REFERENCES

• Matus-Ridley M, Raney RB, Meadows AT. Histiocytosis X in children: patterns of disease and results of treatment. Med Pediatr Oncol 1983;11:99–105.
   PubMedGoogle Scholar
• Ceci A, Terlizzi M, Colella R, et al. Langerhans cell histiocytosis in childhood: results from the Italian Co-operative MEOP-CNR-HX 83 Study. Med Pediatr Oncol. 1993;21:259–264.
   PubMedGoogle Scholar
• McLelland J, Broadbent V, Yeomans E, Malone M, Pritchard J. Langerhans cell histiocytosis: the case for conservative management. Arch Dis Child. 1990;65:301–303.
   Google Scholar
• Raney RB, D'Angio GJ. Langerhans cell histiocytosis (histiocytosis-X) experience at Children's Hos-pital of Philadelphia, 1970-1984. Med Pediatr Oncol. 1989;17:20–28.
   PubMedGoogle Scholar
• Kusumakumary P, Rajeevkumar S, James FV, Chellam VG, Nair MK, Warner RP. Langerhans cell histiocytosis in children: patterns of disease and treatment results in Kerala. Int J Pediatr Hematol Oncol. 1996;3:297–303.
   Google Scholar
• Ladisch S, Gadner H. Treatment of Langerhans cell histiocytosis: evolution and current approaches. Br J Cancer. 1994;23 ( suppl) :S41–S46.
   Google Scholar
• Gadner H, Heitbeg A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr OncoL 1994;23:72–80.
   Google Scholar
• Kusumakumary P, Priyakumari T, Chellam VG, James FV, Nair MK. Langerhans cell histiocytosis in children less than 2 years of age. Indian Pediatr. 1999;36: 29–36.
   Google Scholar
• Berry DH, Gresik MV, Humphry B, et al. Natural history of histiocytosis-X: a Pediatric Oncology Group study. Med Pediatr Oncol 1986;14:1–5.
   PubMedGoogle Scholar
• Dunger DB, Broadbent V, Yeoman E, et al. The frequency and natural history of diabetes insipidus in children with Langerhans cell histiocytosis. N EnglJ Med. 1989;321:1157–1162.
   PubMedGoogle Scholar
• Greenberger JS, Crocker AC, Vawter G, Jaffe N, Cassady JR. Results of treatment of 127 patients with systemic histiocytosis (Letterer-Siwe syndrome, Schuller-Christian syndrome and multifocal eosinophilic granuloma). Medicine. 1984;60: 311–388.
   Google Scholar
• Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay K Disease course and late sequelae of Langerhans cell histioytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996;14:2073–2082.
   PubMedGoogle Scholar
• Komp DM, Elmahdi A, Starling KA, et al. Quality of survival in histiocytosis X: a Southwest Oncology Group study. Med Pediatr Oncol 1980;8:35–40.
   PubMedGoogle Scholar
• Sims DG. Histocytosis-X: follow up of 43 cases. Arch Dis Child. 1977;52:433–440.
   PubMed Web of Science ®Google Scholar
• Cline MJ. Histiocytes and histiocytosis. Blood. 1994;84:2840–2853.
   PubMedGoogle Scholar
• Alessi DM, Maceri D. Histiocytosis-X of the head and neck in a pediatric population. Arch Otolaryngol Head Neck Surg 1992;118:945–948.
   PubMed Web of Science ®Google Scholar
• Filocoma D, Needleman HL, Arceci R, Gelber RD, Donnelly M. Pediatric histiocytosis-X. AmJ Pediatr Hematol OncoL 1992;15:226–230.
   Google Scholar
• Grois N, Flucher-Wolfram B, Heitger A, Mostbeck GH, Hofmann J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from DAL HX-83 study. Med Pediatr Oncol 1995;24:248–256.
   PubMedGoogle Scholar
• Ladisch S, Gadner H, Arico M, et al. LCH-I A randomized trial of etoposide vs vinblastine in dissem-inated Langerhans cell histiocytosis. Med Pediatr OncoL 1994;23:107–110.
   PubMedGoogle Scholar
• Favara BE. Langerhans cell histiocytosis: pathobiology and pathogenesis. Sem Oncol 1991;18:3–7.
   PubMed Web of Science ®Google Scholar
• Scherbaum WA, Wass JAH, Besser GM Bottazzo GF, Doniach D. Autoimmune cranial diabetes in-sipidus: its association with other endocrine diseases and with histiocytosis X. ClinEndocrinol. 1986;25: 411–420.
   Google Scholar
• Fujsawa I, Nishimura K, Asato R, Tageshi K, Itosh K, Noma S. Posterior lobe of pituitary in diabetes insipidus: MR findings. J Comput Assist Tomogr. 1987;11:221–225.
   PubMedGoogle Scholar
• Rosenfield NS, Abrahams J, Komp D. Brain MR in patients with Langerhans cell histiocytosis: findings and enhancement with FD-DTPA. Pediatr RadioL 1990;20:433–436.
   Google Scholar
• Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer. 1994;70 (Suppl) :S37–S40.
   Google Scholar
• Rosenzweig KE, Arceci RJ, Tarbell NJ. Diabetes insipidus secondary to Langerhans cell histiocytosis: Is radiation therapy indicated? Med Pedialr OncoL 1997;29:36–40.
   Google Scholar
• Broadbent V, Pritchard" Diabetes insipidus associated with Langerhans cell histiocytosis: Is it re-versible? Med Pediatr Oncol 1997;28:289–293.
   PubMedGoogle Scholar
• Minehan KJ, Chen MG, Zimmerman D, Su JQ, Colby TV, Shaw EG. Radiation therapy for diabetes insipidus caused by Langerhans cell histioytosis. Int J Radiat Oncol Biol Phys. 1992;23:519–524.
   PubMedGoogle Scholar
• Broadbent V, Pritchard J, Yeoman E. Etoposide in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Med Pediatr OncoL 1989;17:97–100.
   Google Scholar
• Ceci A, Terlizzi M, Balducci D, et al. Etoposide in recurrent childhood Langerhans cell histiocytosis: an Italian co-operative study. Cancer. 1988;62:2528–2531.
   PubMed Web of Science ®Google Scholar
• Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:287–305.
   PubMed Web of Science ®Google Scholar
• Arico M, Egeler M. Clinical aspects of Langerhans cell histiocytsis. Hematol Oncol Clin North Am 1998;12:247–258.
   PubMed Web of Science ®Google Scholar
• Ha SY, Helms P, Fletcher M, Broadbent V, Pritchard J. Lung involvement in Langerhans cell histiocy-tosis: prevalence, clinical features and outcome. Pediatrics. 1992;89:466–469.
   Google Scholar
• Egeler RM, Neglia J, Puccetti DM, Brennan C, Nesbit ME. The association of Langerhans cell histio-cytosis with malignant neoplasms. Cancer. 1993;71:865–873.
   Google Scholar